| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - paraffin section; human; 1:100
| Meng F, Takaori K, Ito T, Masui T, Kawaguchi M, Kawaguchi Y, et al. Expression of SOX9 in intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2014;43:7-14 pubmed publisher |
- immunocytochemistry; human; 1:200
| Becker S, Oelschlaeger T, Wullaert A, Vlantis K, Pasparakis M, Wehkamp J, et al. Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PLoS ONE. 2013;8:e55620 pubmed publisher |
| Zheng S, Yip V, Pedica F, Prachalias A, Quaglia A. Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature. Diagn Pathol. 2015;10:204 pubmed publisher |
| Hirata K, Suzuki H, Imaeda H, Matsuzaki J, Tsugawa H, Nagano O, et al. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br J Cancer. 2013;109:379-86 pubmed publisher |
| Souazé F, Bou Hanna C, Kandel C, Leclair F, Devalliere J, Charreau B, et al. Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study. PLoS ONE. 2013;8:e55904 pubmed publisher |
| Lee H, Cho M, Kim T. Prognostic significance of muc4 expression in gallbladder carcinoma. World J Surg Oncol. 2012;10:224 pubmed publisher |
| Szachnowicz S, Cecconello I, Ribeiro U, Iriya K, El Ibrahim R, Takeda F, et al. Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study. World J Surg Oncol. 2009;7:27 pubmed publisher |
| Westgaard A, Schjølberg A, Cvancarova M, Eide T, Clausen O, Gladhaug I. Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology. 2009;54:337-47 pubmed publisher |
